Request to Join
has invited you to join this group
Given the potential to reimagine and revolutionize how care is delivered through seamless integration of clinical-grade wearable sensors, predictive analytics, mobile apps, connectivity, med management, patient education & engagement and other transformative experiences, what innovations can you propose that would further the Triple Aim in the management of patients with chronic diseases? Participants are encouraged to think of holistic ways of solving these tough, multi-disciplinary challenges through combination of technology around wearables, software & analytics to help make meaningful decisions. This is an open call for submissions from any interested party, including clinicians, engineers, entrepreneurs, patients, caregivers, designers, artists, etc. #PhilipsWearablesChallenge
Given the potential to reimagine and revolutionize how care is delivered through seamless integration of clinical-grade wearable sensors, predictive analytics, mobile apps, connectivity, med management, patient education & engagement and other transformative experiences, what innovations can you...Read More
John S. Rumsfeld, MD, PhD, FACC is the Chief Innovation Officer for the American College of Cardiology (ACC), the 52,000 member non-profit professional association for cardiovascular clinicians in the U.S. and abroad. In this role, Dr. Rumsfeld is responsible for developing a long-term innovation agenda to help the ACC maintain its competitive advantage in the global marketplace, investigating global and domestic market trends in the delivery of cardiovascular care and health information technology, and exploring new technologies and team-based approaches to health care.
I am a principal at the Longwood Fund, an early-stage venture capital firm, where I invest in healthcare and life sciences companies and collaborate to build new ventures. Alongside my role at Longwood, I am an attending hospitalist at the Massachusetts General Hospital within the Hospital Medicine Unit and an Instructor in Medicine at Harvard Medical School.
YiDing Yu a practicing primary care physician, researcher, innovator, entrepreneur, and designer. She was Founder and CEO of Twiage and formerly Chief Innovation Engineer at Atrius Health. As a physician, YiDing is passionate about improving health care delivery to provide timely, high-quality, cost-effective care to her patients. She has received the President's Prize for Value-Based Healthcare at Partners Healthcare, the Martin P. Solomon Award for Primary Care at the Brigham and Women's Hospital, and the Massachusetts Medical Society Information Technology Award in recognition of her work in healthcare innovation. YiDing has been named a 40 Under 40 Healthcare Innovator, a 40 Under 40 Honoree by the Boston Business Journal, and Becker's Hospital Review Rising Star. Trained in economics and health policy at Harvard, YiDing has conducted research as a Doris Duke Clinical Research Fellow, published in medical journals, presented at national conferences, and was most recently recognized by the Johns Hopkins Diane Becker Research Award in Clinical Epidemiology. As a resident, YiDing founded Twiage, a HIPAA-compliant platform that seamlessly bridges communication between ambulances and hospitals to deliver more timely and cost-effective patient care at the most crucial moments. In her free time, YiDing designs and volunteers for philanthropic causes. She is a Board Member for Burma Border Projects, a non-profit organization dedicated to providing trauma counseling and mental health support for refugees and internally displaced persons in Burma.
Nicole Hijnen works at Philips, where she is focused on solving clinical challenges through wearables, software & analytics solutions.
Naomi Fried, PhD, is the founder and CEO of Health Innovation Strategies, a boutique consulting firm. Health Innovation Stategies focuses on innovation program design and optimization, digital health strategy, and online challenge planning and execution. Health Innovation Strategies advises providers, payers, and pharma.
Naomi is a thought leader in innovation and digital health and the creator of the "Innovation Life Cycle" paradigm. She has extensive experience in digital health, and am passionate about the way it will transform healthcare.
While VP of Innovation and External Partnerships at Biogen, she developed the vision and strategy for the "Innovation Beyond the Molecule" program. Prior to that, as the first Chief Innovation Officer at Boston Children’s Hospital, Naomi launched and built the ground-breaking, highly successful Innovation Acceleration Program. Previously, she was Kaiser Permanente’s first Vice President of Innovation and Advanced Technology.
I am an emergency medicine physician and medical toxicologist at the Brigham and Women's Hospital and Harvard Medical School. My research focuses on the intersection of technology and health. I have led pilot deployments of wearable devices and smart glasses in the emergency department to detect and respond to worsening illness and substance abuse.
For a list of citations pleas see: http://www.ncbi.nlm.nih.gov/sites/myncbi/peter.chai.1/bibliography/47858651/public/?sort=date&direction= descending
As the Senior Director of Connected Health Innovation, Dr. Jethwani is responsible for leading a multidisciplinary team to identify and solve challenges in health care delivery using innovative technology-based solutions. As an organization that is embracing value-based reimbursement across all care settings, his solutions enable improved outcomes by making care delivery a continuous function of patients’ lives. His team is engaged in needs assessments across the system, product development and evaluations, as well as rigorous research to prove the value and outcomes of using connected health solutions. These innovations are routinely scaled within clinical practices at Partners, and made part of the usual care provided to patients.
Carlos is the Founder & Managing Director of Volar Health, LLC — an operations-focused consultancy that helps innovative health companies refine their product strategy and rapidly commercialize their solutions. Areas of expertise include digital health, wearables, biosensors, Internet-of-Things, and genomics.
Previously, Carlos was co-founder & CEO of HealthRhythms, a digital health startup utilizing smartphone sensor technology to quantify behavioral health parameters. Beforehand, at PatientsLikeMe, the leading peer-to-peer research platform, he oversaw strategic partnerships with pharma and biotech, and developed the company’s wearables and biosensors capabilities. After spending 10,000+ hours as a consultant with The Frankel Group (acquired by Huron Consulting Group), Carlos developed a passion for direct-to-consumer healthcare models, identifying methods to engage patients in care, and generating clinical evidence through novel research methodologies.
Carlos is an active startup mentor, member of several advisory boards, and recognized speaker on health innovation. In 2015, Carlos was named a "40 under 40 Healthcare Innovator" by MedTech Boston and in 2016 a “Top 100 Digital Health Influencer” by Onalytica.
Ivan S. Salgo, MD, MS, MBA is Associate Chief Medical Officer for Philips. In his role, he is involved in medical device technology strategy and linking those to business new models. He is part of an innovations team that focused on leading a broad-based medical, science and technology areas to bring clinically meaningful innovation to the bedside. Prior to joining PCMS, Ivan help several roles in Philips Ultrasound bringing echo innovations to clinical practice. This included serving as R&D lead for signal & image processing groups that developed diagnostic solutions for structural heart disease and heart failure. In 2007, this culminated in 3DTEE being launched and adopted to be standard of care for mitral valve repair. Ivan also served as leader for the Global Cardiology Segment for the platform launch of EPIQ 7 in 2013 and Affiniti 70 in 2014, which are Philips flagship echocardiography ultrasound systems.
Sanjeev Bhavnani MD is a cardiologist and physician-scientist in healthcare innovation and practice transformation at Scripps Clinic and Research Foundation. Dr. Bhavnani was a Qualcomm Wireless Health Scholar at TSRI where he was involved in the design of next generation digital medicine clinical trials. As a principle investigator on several studies, he has designed trials using nanosensors, wireless mHealth and smartphone-connected devices, handheld ultrasound, lab-on-a-chip technologies and cloud-based data platforms across various patient populations, and to assess the impact of new technologies on healthcare quality, costs, and outcomes. These trials have been executed across the US and in resource limited areas – Uganda, India, and Mexico – where he and his team have designed the first smartphone-connected mHealth clinics . To date, these mHealth clinics have enrolled 20,000+ patients. Dr. Bhavnani works with teams of clinicians, researchers, biomedical engineers, translational informatics, and biostatisticians. He serves on the innovation advisory boards of several national medical societies and has worked with digital health think tanks to develop the CONNECT legislation and 21st Century Cures Act. He is board certified in internal medicine, cardiovascular diseases, nuclear cardiology, echocardiography, and clinical informatics, and has been recognized as a 'Top Doc' and 40-under-40 life science innovators in San Diego.
Brownstein was trained as an epidemiologist at Yale University, where he received his PhD. Dr. Brownstein’s research interests are in the development of methods and data sources in public health informatics which focuses on two major areas: (1) the design, evaluation and implementation of public health surveillance systems and (2) statistical modeling of public health surveillance data to improve prevention and control activities. This research has focused on a variety of infectious disease systems including malaria, HIV, dengue, West Nile virus, Lyme disease, RSV, salmonella, listeria and influenza. Current research activities focus on predicting patterns of influenza epidemics and pandemics, with specific interests in the efficacy of disease control strategies including vaccination, quarantine and travel restrictions.